All Phenotypes Tg(Lck-LMO1)11Sjk MGI Mouse

Phenotypes associated with this allele

Jump to	Allelic Composition	Genetic Background	Genotype ID
cn1	Ccnc^tm1.1Pisc/Ccnc^tm1.1Pisc Tg(Lck-LMO1)11Sjk/0 Tg(Mx1-cre)1Cgn/0	Not Specified	MGI:5697722
cx2	Tg(Lck-LMO1)11Sjk/0 Tg(STIL-TAL1)A5.3Alpa/0	involves: C3H * C3H/HeRos * C57BL/6 * C57BL/10Ros	MGI:4819172
tg3	Tg(Lck-LMO1)11Sjk/0	involves: C3H * C57BL/6	MGI:4819174

Allelic Composition	Ccnc^tm1.1Pisc/Ccnc^tm1.1Pisc Tg(Lck-LMO1)11Sjk/0 Tg(Mx1-cre)1Cgn/0
Genetic Background	Not Specified

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Ccnc^tm1.1Pisc mutation (0 available); any Ccnc mutation (25 available)
Tg(Lck-LMO1)11Sjk mutation (0 available)
Tg(Mx1-cre)1Cgn mutation (10 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

neoplasm

increased T cell derived lymphoma incidence ( J:217695 )

• strongly increased tumour incidence of T-ALL with elevated ICN1 levels in mutant tumors

endocrine/exocrine glands

increased T cell derived lymphoma incidence ( J:217695 )

• strongly increased tumour incidence of T-ALL with elevated ICN1 levels in mutant tumors

immune system

increased T cell derived lymphoma incidence ( J:217695 )

• strongly increased tumour incidence of T-ALL with elevated ICN1 levels in mutant tumors

hematopoietic system

increased T cell derived lymphoma incidence ( J:217695 )

• strongly increased tumour incidence of T-ALL with elevated ICN1 levels in mutant tumors

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

hematopoietic system

enlarged thymus ( J:40868 )

increased T cell derived lymphoma incidence ( J:40868 )

• 95% of mice develop aggressive T cell leukemia/lymphomas within 6 months

enlarged spleen ( J:40868 )

decreased bone marrow cell number ( J:40868 )

• lymphoblasts replace bone marrow

decreased erythrocyte cell number ( J:40868 )

thrombocytopenia ( J:40868 )

increased leukocyte cell number ( J:40868 )

• in some mice

neoplasm

increased T cell derived lymphoma incidence ( J:40868 )

• 95% of mice develop aggressive T cell leukemia/lymphomas within 6 months

increased leukemia incidence ( J:40868 )

• 95% of mice develop aggressive T cell leukemia/lymphomas within 6 months

behavior/neurological

lethargy ( J:40868 )

liver/biliary system

enlarged liver ( J:40868 )

respiratory system

respiratory distress ( J:40868 )

immune system

enlarged thymus ( J:40868 )

increased T cell derived lymphoma incidence ( J:40868 )

• 95% of mice develop aggressive T cell leukemia/lymphomas within 6 months

enlarged spleen ( J:40868 )

increased leukocyte cell number ( J:40868 )

• in some mice

enlarged lymph nodes ( J:40868 )

• peripheral

abnormal inflammatory response ( J:40868 )

• mice exhibit widespread organ infiltration including liver, kidney, lung, and bone marrow

endocrine/exocrine glands

enlarged thymus ( J:40868 )

increased T cell derived lymphoma incidence ( J:40868 )

• 95% of mice develop aggressive T cell leukemia/lymphomas within 6 months

growth/size/body

enlarged liver ( J:40868 )

enlarged spleen ( J:40868 )

Mouse Models of Human Disease		DO ID	OMIM ID(s)	Ref(s)
acute lymphoblastic leukemia		DOID:9952	OMIM:247640 OMIM:613065	J:40868

Allelic Composition	Tg(Lck-LMO1)11Sjk/0
Genetic Background	involves: C3H * C57BL/6

Find Mice

Using the International Mouse Strain Resource (IMSR)
No mouse lines available in IMSR.
See publication links below for author information.

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

neoplasm

neoplasm ( J:40868 )

N	• mice do not develop T cell malignancy by 6 months of age

Contributing Projects: Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support.	last database update 10/07/2025 MGI 6.24